LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
This Quarter Return
-2.53%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$4.19B
AUM Growth
+$4.19B
(-28%)
Cap. Flow
-$1.38B
Cap. Flow
% of AUM
-33%
Top 10 Holdings %
Top 10 Hldgs %
60.37%
Holding
590
New
204
Increased
36
Reduced
84
Closed
160
Top Buys
| 1 |
Qualcomm
QCOM
|
$182M |
| 2 |
Vistra
VST
|
$180M |
| 3 |
DISCA
Discovery, Inc. Series A Common Stock
DISCA
|
$170M |
| 4 |
Micron Technology
MU
|
$148M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$125M |
Top Sells
| 1 |
Marathon Petroleum
MPC
|
$413M |
| 2 |
VMW
VMware, Inc
VMW
|
$279M |
| 3 |
Occidental Petroleum
OXY
|
$217M |
| 4 |
eBay
EBAY
|
$211M |
| 5 |
PG&E
PCG
|
$206M |
Sector Composition
| 1 | Healthcare | 25.19% |
| 2 | Technology | 14.33% |
| 3 | Consumer Discretionary | 11.38% |
| 4 | Communication Services | 9.28% |
| 5 | Materials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Aclaris Therapeutics
ACRS
$223M
| $24.8M | 0.3% |
1,440,075
+325,000
| +29% | +$5.6M |
|
27
Travere Therapeutics
TVTX
$1.75B
| $22.4M | 0.27% |
868,778
-40,173
| -4% | -$1.04M |
|
28
Halliburton
HAL
$18.4B
| $19.4M | 0.24% |
512,220
-367,800
| -42% | -$13.9M |
|
29
iShares China Large-Cap ETF
FXI
$6.65B
| $16.6M | 0.2% |
520,000
+264,584
| +104% | +$8.46M |
|
30
Home Depot
HD
$406B
| $15.4M | 0.19% |
+51,608
| New | +$15.4M |
|
31
Vontier
VNT
$6.24B
| $14.6M | 0.18% |
574,353
-1,568,935
| -73% | -$39.8M |
|
32
Neurocrine Biosciences
NBIX
$13.5B
| $14.4M | 0.18% |
+154,068
| New | +$14.4M |
|
|
SRRA
33
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $13.6M | 0.17% |
+425,000
| New | +$13.6M |
|
|
RXDX
34
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $12.4M | 0.15% |
328,167
| – | – |
|
|
KDNY
35
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $12.3M | 0.15% |
754,750
+200,500
| +36% | +$3.28M |
|
36
Goldman Sachs
GS
$221B
| $12.1M | 0.15% |
36,774
+29,706
| +420% | +$9.81M |
|
37
Eli Lilly
LLY
$661B
| $11.6M | 0.14% |
40,524
+38,377
| +1,787% | +$11M |
|
|
NVRO
38
DELISTED
NEVRO CORP.
NVRO
| $11.5M | 0.14% |
+158,917
| New | +$11.5M |
|
39
Wells Fargo
WFC
$258B
| $10.8M | 0.13% |
222,600
-32,460
| -13% | -$1.57M |
|
40
CME Group
CME
$97.1B
| $10.7M | 0.13% |
45,004
| – | – |
|
41
FIGS
FIGS
$1.08B
| $10.7M | 0.13% |
+496,806
| New | +$10.7M |
|
42
AdaptHealth
AHCO
$1.23B
| $10.1M | 0.12% |
+629,557
| New | +$10.1M |
|
|
SGEN
43
DELISTED
Seagen Inc. Common Stock
SGEN
| $9.94M | 0.12% |
+68,984
| New | +$9.94M |
|
44
AbbVie
ABBV
$374B
| $9.82M | 0.12% |
+60,586
| New | +$9.82M |
|
45
Rigel Pharmaceuticals
RIGL
$710M
| $9.82M | 0.12% |
3,284,400
+300,000
| +10% | +$897K |
|
46
Mastercard
MA
$536B
| $9.65M | 0.12% |
27,003
+25,243
| +1,434% | +$9.02M |
|
|
SWTX
47
DELISTED
SpringWorks Therapeutics
SWTX
| $9.45M | 0.12% |
167,384
-17,877
| -10% | -$1.01M |
|
48
Microsoft
MSFT
$3.76T
| $9.12M | 0.11% |
+29,573
| New | +$9.12M |
|
49
Adicet Bio
ACET
$60.8M
| $8.82M | 0.11% |
441,518
-73,482
| -14% | -$1.47M |
|
50
Novavax
NVAX
$1.2B
| $8.16M | 0.1% |
+110,822
| New | +$8.16M |
|